| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $206,855,449 ) (Continued on the next page) |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01GM148392 | CD11c as a novel target to improve neutrophil effector functions and sepsis outcome | 001 | 2 | NIH | 6/10/2024 | $38,642 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01GM148392 | CD11c as a novel target to improve neutrophil effector functions and sepsis outcome | 000 | 2 | NIH | 12/18/2023 | $347,791 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01ES034713 | Interdisciplinary approaches for understanding how arsenic and micronutrients affect the epigenome to influence spina bifida risk | 000 | 2 | NIH | 12/27/2023 | $759,230 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EY034846 | Development of Oculomotor Circuits in Nystagmus | 000 | 1 | NIH | 12/15/2023 | $442,500 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R21EY035902 | Elucidating synaptic motifs in the visual thalamus | 000 | 1 | NIH | 11/17/2023 | $221,250 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R03NS127044 | Combining Brain Connectivity and Excitability to Plan Epilepsy Surgery in Children: A New Approach to Augment Presurgical Intracranial Electroencephalography | 000 | 2 | NIH | 12/11/2023 | $88,500 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32DK141214 | Discovering the Consequences of Genetic Variation in Nephrin on Kidney Diseases and Traits in Biobank Populations | 000 | 1 | NIH | 7/17/2024 | $87,064 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | F32DK141214 | Discovering the Consequences of Genetic Variation in Nephrin on Kidney Diseases and Traits in Biobank Populations | 001 | 1 | NIH | 7/17/2024 | $0 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL171405 | Pericyte contribution to capillary remodeling in pulmonary arterial hypertension | 001 | 1 | NIH | 7/6/2024 | $80,613 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL171405 | Pericyte contribution to capillary remodeling in pulmonary arterial hypertension | 000 | 1 | NIH | 12/15/2023 | $725,514 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | UM1HL172702 | Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital | 000 | 1 | NIH | 12/29/2023 | $497,813 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS138758 | Molecular pathways that strengthen GABAergic inhibition and reduce seizure susceptibility | 000 | 1 | NIH | 7/1/2024 | $535,389 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK115217 | Type III interferon Control of Mucosal Immunity | 003 | 6 | NIH | 5/14/2024 | $46,646 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK115217 | Type III interferon Control of Mucosal Immunity | 002 | 6 | NIH | 12/27/2023 | $699,678 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK124328 | Role of TAZ in metabolic regulation in both normal and insulin resistant states | 001 | 4 | NIH | 5/7/2024 | $27,087 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DK124328 | Role of TAZ in metabolic regulation in both normal and insulin resistant states | 000 | 4 | NIH | 11/16/2023 | $406,311 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DC008853 | Functional development of hair cells and neurons in the inner ear | 001 | 14 | NIH | 5/2/2024 | $53,865 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01DC008853 | Functional development of hair cells and neurons in the inner ear | 000 | 14 | NIH | 11/15/2023 | $484,792 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL118455 | Integrative Genomics of Acute Asthma Control | 001 | 8 | NIH | 6/21/2024 | $58,807 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL118455 | Integrative Genomics of Acute Asthma Control | 000 | 8 | NIH | 1/13/2024 | $661,577 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152133 | Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria | 000 | 4 | NIH | 11/6/2023 | $517,939 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL151450 | Regulation of endothelial cell specification | 001 | 4 | NIH | 6/20/2024 | $47,650 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL151450 | Regulation of endothelial cell specification | 000 | 4 | NIH | 1/3/2024 | $536,054 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152063 | Single cell, whole genome analysis of the aging human cardiomyocyte | 002 | 4 | NIH | 6/12/2024 | $67,218 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152063 | Single cell, whole genome analysis of the aging human cardiomyocyte | 001 | 4 | NIH | 4/5/2024 | $61,548 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152063 | Single cell, whole genome analysis of the aging human cardiomyocyte | 000 | 4 | NIH | 12/21/2023 | $756,217 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL150106 | Pericytes differentiate into smooth muscle cells through HIF2a/SDF1 activation | 001 | 4 | NIH | 6/12/2024 | $44,250 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL150106 | Pericytes differentiate into smooth muscle cells through HIF2a/SDF1 activation | 000 | 4 | NIH | 12/8/2023 | $398,250 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152133 | Enhancing endothelial cell engraftment via transplantation of exogenous mitochondria | 001 | 4 | NIH | 6/13/2024 | $46,039 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL156362 | The role of signaling adaptor protein epsin in atherosclerosis | 001 | 4 | NIH | 6/13/2024 | $62,873 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL156362 | The role of signaling adaptor protein epsin in atherosclerosis | 000 | 4 | NIH | 11/10/2023 | $707,330 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R37AI116550 | Defining the pathways activated by Toll-like Receptors to stimulate immunity | 001 | 8 | NIH | 5/23/2024 | $53,099 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K08DK120871 | The Role of Wnt2b in Intestinal Health | 000 | 5 | NIH | 12/7/2023 | $168,005 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS124879 | Developmentally Programmed Remodeling of Apical ECM | 000 | 3 | NIH | 11/7/2023 | $393,522 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01EY032539 | Molecular mechanisms underlying strabismus risk | 000 | 3 | NIH | 12/15/2023 | $654,321 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL155632 | Transcription Factor 4 Maintain Endothelial identity to Oppose Heart Failure | 001 | 3 | NIH | 6/24/2024 | $40,137 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL155632 | Transcription Factor 4 Maintain Endothelial identity to Oppose Heart Failure | 000 | 3 | NIH | 11/7/2023 | $451,532 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS121334 | Fetal Brain MRI as a Predictor of Late Neurodevelopmental Outcome in Congenital Heart Disease | 001 | 3 | NIH | 4/10/2024 | $32,670 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS121334 | Fetal Brain MRI as a Predictor of Late Neurodevelopmental Outcome in Congenital Heart Disease | 000 | 3 | NIH | 12/28/2023 | $420,029 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS120986 | Predicting ASD and Other Developmental Outcomes in the First Year of Life Using EEG in a Diverse Community-Based Sample | 001 | 3 | NIH | 4/11/2024 | $47,744 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01NS120986 | Predicting ASD and Other Developmental Outcomes in the First Year of Life Using EEG in a Diverse Community-Based Sample | 000 | 3 | NIH | 12/1/2023 | $613,843 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R37AI116550 | Defining the pathways activated by Toll-like Receptors to stimulate immunity | 000 | 8 | NIH | 1/23/2024 | $477,901 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AI126915 | Immunological and Microbial Mechanisms in Food Allergy | 002 | 7 | NIH | 5/24/2024 | $62,760 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01AI126915 | Immunological and Microbial Mechanisms in Food Allergy | 000 | 7 | NIH | 1/16/2024 | $564,838 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152358 | Exploring the relationship between advanced multimodal brain MRI phenotypes, genes and cognitive outcome in adults with CHD | 001 | 4 | NIH | 6/19/2024 | $62,612 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL152358 | Exploring the relationship between advanced multimodal brain MRI phenotypes, genes and cognitive outcome in adults with CHD | 000 | 4 | NIH | 1/25/2024 | $704,383 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | R01HL162367 | The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis | 001 | 3 | NIH | 7/11/2024 | $58,992 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | K00MH133546 | Role of glycosylation in environmental and genetic schizophrenia risk | 000 | 3 | NIH | 12/5/2023 | $86,065 |
| 2024 | 2024 | CHILDREN'S HOSPITAL CORPORATION, THE | 300 LONGWOOD AVE | BOSTON | MA | 02115-5724 | SUFFOLK | USA | T2537594 | Addiction Medicine Fellowship | 01 | 5 | HRSA | 7/23/2024 | $24,612 |
|